Workflow
巍华新材(603310.SH):暂无创新药相关方面的研发布局

Group 1 - The company, Wehua New Materials (603310.SH), primarily produces chlorotoluene and trifluoromethylbenzene series intermediate products [1] - Currently, the company does not have any research and development plans related to innovative drugs [1]